Advertisement

Minimal Computed Tomography Attenuation Value Within the Hematoma is Associated with Hematoma Expansion and Poor Outcome in Intracerebral Hemorrhage Patients

  • Heling Chu
  • Chuyi Huang
  • Jing Dong
  • Xiaobo Yang
  • Jun Xiang
  • Yiting Mao
  • Qiang DongEmail author
  • Yuping TangEmail author
Original work

Abstract

Background

Early hematoma expansion in intracerebral hemorrhage (ICH) patients is associated with poor outcome. We aimed to investigate whether the minimal computed tomography (CT) attenuation value predicted hematoma expansion and poor outcome.

Methods

This study involved spontaneous ICH patients of two cohorts who underwent baseline CT scan within 6 h after ICH onset and follow-up CT scan within 24 h after initial CT scan. We determined the critical value of the minimal CT attenuation value via retrospective analysis of the data from a derivation cohort. Then, a prospective study on the validation cohort of three clinical centers was performed for determining the association between the minimal CT attenuation value and hematoma expansion as well as poor outcome (modified Rankin Scale scores > 3) at 90 days by using univariate and multivariate logistic regression analyses.

Results

One hundred and forty eight ICH patients were included in the derivation cohort. Minimal CT attenuation value ≤ 31 Hounsfield units (HU) was demonstrated as the critical value to predict hematoma expansion by using receiver operating characteristic analysis. A total of 311 ICH patients were enrolled in the validation cohort, 86 (27.7%) and 133 (42.8%) of which were found hematoma expansion and poor outcome. Minimal CT attenuation value ≤ 31 HU was positive in 73 patients (23.5%). The multivariate logistic regression analysis demonstrated minimal CT attenuation value and minimal CT attenuation value ≤ 31 HU independently predicted hematoma expansion (p < 0.001) and poor outcome (p < 0.001). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of minimal CT attenuation value ≤ 31 HU for hematoma expansion and poor outcome prediction were 64.0, 92.0, 75.3, 87.0, 84.2 and 45.1%, 92.7%, 82.2%, 69.3%, 72.3%, respectively.

Conclusions

The minimal CT attenuation value independently predicts early hematoma expansion and poor outcome in patients with ICH.

Keywords

Hematoma expansion Intracerebral hemorrhage Minimal CT attenuation value Noncontrast computed tomography Poor outcome 

Notes

Author Contributions

HC and CH contributed to study design, data collection, and analysis and drafting of the manuscript. JD, XY, JX, and YM involved in data collection and analysis. QD and YT took part in conception and design, acquisition of clinical data, revision and approval of the manuscript. All authors gave the final approval of the version to be published. Authorship requirements have been met, and the final manuscript was approved by all authors. This manuscript has not been published elsewhere and is not under consideration by another journal.

Source of Support

This research was supported by grants from the National Natural Science Foundation of China (Nos. 81500998; 81701244; 81801290), Science and Technology Commission of Shanghai Municipality (No. 16140903200), and Shanghai Sixth People’s Hospital Medical Group (2017LY01).

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical Approval/Informed Consent

All patients or their next-of-kin gave their informed consent prior to inclusion in this study. This study was approved by and studied in accordance with the ethical standards of the Ethics Committee of Fudan University.

References

  1. 1.
    van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–76.CrossRefPubMedGoogle Scholar
  2. 2.
    Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Dowlatshahi D, Demchuk AM, Flaherty ML, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238–44.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke. 2009;40:2994–3000.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Barras CD, Tress BM, Christensen S, et al. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke. 2009;40:1325–31.CrossRefPubMedGoogle Scholar
  7. 7.
    Sporns PB, Schwake M, Kemmling A, et al. Comparison of spot sign, blend sign and black hole sign for outcome prediction in patients with intracerebral hemorrhage. J Stroke. 2017;19:333–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Li Q, Zhang G, Huang YJ, et al. Blend sign on computed tomography: novel and reliable predictor for early hematoma growth in patients with intracerebral hemorrhage. Stroke. 2015;46:2119–23.CrossRefPubMedGoogle Scholar
  9. 9.
    Li Q, Zhang G, Xiong X, et al. Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke. 2016;47:1777–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Selariu E, Zia E, Brizzi M, Abul-Kasim K. Swirl sign in intracerebral haemorrhage: definition, prevalence, reliability and prognostic value. BMC Neurol. 2012;12:109.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Xu X, Chen X, Zhang J, et al. Comparison of the Tada formula with software slicer: precise and low-cost method for volume assessment of intracerebral hematoma. Stroke. 2014;45:3433–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389:603–11.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Boulouis G, Morotti A, Brouwers HB, et al. Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73:961–8.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasationon CT angiography predicts hematoma expansion inintracerebral hemorrhage. Neurology. 2007;68:889–94.CrossRefPubMedGoogle Scholar
  17. 17.
    Sporns PB, Schwake M, Kemmling A, Minnerup J, Schwindt W, Niederstadt T, et al. Comparison of spot sign, blend sign and black hole sign for outcome prediction in patients with intracerebral hemorrhage. J Stroke. 2017;19:333–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Boulouis G, Morotti A, Brouwers HB, et al. Noncontrast computed tomography hypodensities predict poor outcome in intracerebral hemorrhage patients. Stroke. 2016;47:2511–6.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Dong J, Yang X, Xiang J, et al. Hypodensities detected at 1.5–3 h after intracerebral hemorrhage better predicts secondary neurological deterioration. J Neurol Sci. 2019;396:219–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Morotti A, Boulouis G, Romero JM, et al. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology. 2017;89:548–54.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    New PF, Aronow S. Attenuation measurements of whole blood and blood fractions in computed tomography. Radiology. 1976;121:635–40.CrossRefPubMedGoogle Scholar
  22. 22.
    Schlunk F, Greenberg SM. The pathophysiology of intracerebral hemorrhage formation and expansion. Transl Stroke Res. 2015;6:257–63.CrossRefPubMedGoogle Scholar
  23. 23.
    Wolverson MK, Crepps LF, Sundaram M, Heiberg E, Vas WG, Shields JB. Hyperdensity of recent hemorrhage at body computed tomography: incidence and morphologic variation. Radiology. 1983;148:779–84.CrossRefPubMedGoogle Scholar
  24. 24.
    Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN. Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke. 2017;48:1120–5.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Brouwers HB, Chang Y, Falcone GJ, et al. Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol. 2014;71:158–64.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Morotti A, Dowlatshahi D, Boulouis G, et al. Predicting intracerebral hemorrhage expansion with noncontrast computed tomography: the BAT score. Stroke. 2018;49:1163–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Chu H, Huang C, Dong J, et al. Lactate dehydrogenase predicts early hematoma expansion and poor outcomes in intracerebral hemorrhage patients. Transl Stroke Res. 2019;1:1.  https://doi.org/10.1007/s12975-019-0686-7.CrossRefGoogle Scholar
  28. 28.
    Morotti A, Brouwers HB, Romero JM, et al. Intensive blood pressure reduction and spot sign in intracerebral hemorrhage: a secondary analysis of a randomized clinical trial. JAMA Neurol. 2017;74:950–60.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Meretoja A, Churilov L, Campbell BC, et al. The spot sign and tranexamic acid on preventing ICH growth–AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial. Int J Stroke. 2014;9:519–24.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2019

Authors and Affiliations

  • Heling Chu
    • 1
  • Chuyi Huang
    • 2
  • Jing Dong
    • 1
  • Xiaobo Yang
    • 3
  • Jun Xiang
    • 4
  • Yiting Mao
    • 1
  • Qiang Dong
    • 1
    Email author
  • Yuping Tang
    • 1
    Email author
  1. 1.Department of Neurology, Huashan Hospital, State Key Laboratory of Medical NeurobiologyFudan UniversityShanghaiChina
  2. 2.Department of Neurology, Shanghai East HospitalTongji University School of MedicineShanghaiChina
  3. 3.Department of Neurology, Jinshan HospitalFudan UniversityShanghaiChina
  4. 4.Department of Chinese Integrative Medicine, Zhongshan HospitalFudan UniversityShanghaiChina

Personalised recommendations